Laura Benjamin
Direktor/Vorstandsmitglied bei ALLARITY THERAPEUTICS, INC.
Aktive Positionen von Laura Benjamin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - | |
Oncxerna Therapeutics, Inc.
 Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
| Vorstandsvorsitzender | 01.01.2018 | - | |
| Gründer | 01.01.2018 | - | |
| Präsident | 01.01.2018 | - | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - |
Karriereverlauf von Laura Benjamin
Ausbildung von Laura Benjamin
| University of Pennsylvania | Doctorate Degree |
| Barnard College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Dänemark | 2 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Börse
- Insiders
- Laura Benjamin
- Erfahrung
